Sender CO & Partners, Inc. Bellus Health Inc. Transaction History

Sender CO & Partners, Inc.

  • $41.4 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022
SELL
$5.56 - $7.99 $604,477 - $868,664
-108,719 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.26 - $8.3 $571,861 - $902,367
108,719 New
108,719 $875,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Sender CO & Partners, Inc. Portfolio

Follow Sender CO & Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sender CO & Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sender CO & Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email